The phenomenon of multidrug resistance in glioblastomas

Hematol Oncol Stem Cell Ther. 2021 Jun 16:S1658-3876(21)00057-1. doi: 10.1016/j.hemonc.2021.05.006. Online ahead of print.


The most common and aggressive brain tumor in the adult population is glioblastoma (GBM). The lifespan of patients does not exceed 22 months. One of the reasons for the low effectiveness of GBM treatment is its radioresistance and chemoresistance. In the current review, we discuss the phenomenon of multidrug resistance of GBM in the context of the expression of ABC family transporter proteins and the mechanisms of proliferation, angiogenesis, and recurrence. We focused on the search of molecular targets among growth factors, receptors, signal transduction proteins, microRNAs, transcription factors, proto-oncogenes, tumor suppressor genes, and their single-nucleotide polymorphisms.

PMID:34216549 | DOI:10.1016/j.hemonc.2021.05.006